| Literature DB >> 35449839 |
Abstract
Uterine adhesions are mainly manifested as menstrual changes in women of childbearing age and affect fertility. Resection of uterine adhesions can well restore the shape of the patient's uterine cavity and improve the patient's menstruation. However, how to promote the growth of the endometrium and prevent the recurrence of adhesions after the operation is still a major problem. This article aims to study the use of traditional treatment methods as a control and use low-frequency nerve therapy device to assist in the treatment of posterior intrauterine adhesions recurrence rate, menstrual recovery effective rate, adverse reaction rate, liver function, etc. to study the low-frequency nerve therapy device auxiliary treatment method to prevent the postoperative effect of intrauterine adhesions. This article proposes an image processing algorithm based on intelligent medical related algorithms such as deep learning, Apriori algorithm, and an improved algorithm that introduces the degree of interest and details of 140 patients diagnosed with moderate to severe intrauterine adhesions who underwent hysteroscopic TCRA surgery in a certain affiliated hospital. The medical records were followed up by hysteroscopy and electric resection, and they were randomly divided into a control group and an observation group, with 70 cases in each group. Both groups of patients were closely monitored postoperatively, followed by postoperative review, and recorded menstrual recovery and pregnancy. At the same time, we performed hysteroscopy for recurrence of endometrial adhesions. The experimental results of this article show that the actual treatment rate of the control group is 65.7%, which is much lower than the 95.7% of the experimental group. The probability of returning to normal after 3 months of menstruation in the control group was 34.0%, much lower than the 69% in the experimental group. Three months after operation, the endometrial thickness of the experimental group was much higher than that of the control group, and the RI was lower than that of the control group. The difference was statistically significant (P < 0.05). The clinical treatment results are satisfactory and worthy of clinical screening.Entities:
Mesh:
Year: 2022 PMID: 35449839 PMCID: PMC9017449 DOI: 10.1155/2022/2929800
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 3.822
Figure 1Progressive upsampling.
Figure 2Intelligent medical big data platform architecture.
General conditions of patients.
| Project | Control group | Observation group |
|---|---|---|
| Average age | 32.47 ± 5.2 years old | 32.35 ± 4.26 years old |
| Average number of uterine cavity operations | 2.15 ± 1.5 times | 2.25 ± 1.4 times |
| A history of abortion | 20 cases (14.26%) | 20 cases (14.26%) |
| History of multiple abortions | 30 cases (21.43%) | 27 cases (19.29%) |
| Purging the palace after a missed abortion | 9 cases (6.43%) | 11 cases (7.86%) |
| Hydatidiform mole | 1 cases (0.71%) | 1 cases (0.71%) |
| Other non-pregnancy factors uterine cavity operation | 5 cases (3.57%) | 6 cases (3.57%) |
Figure 3Comparison of clinical treatment effects of moderate to severe intrauterine adhesions (a) Before treatment of severe intrauterine adhesions (b) After treatment of severe intrauterine adhesions.
Figure 4Comparison of the effect before and after clinical treatment of moderate to severe intrauterine adhesions in the experimental group.
Comparison of short-term efficacy between the two groups.
| Group | Total number of cases | Cured ( | Markedly effective ( | Ineffective ( | Total effective ( |
|---|---|---|---|---|---|
| Test group | 70 | 28 | 39 | 3 | 67 (95.7) |
| Control group | 70 | 14 | 32 | 24 | 46 (65.7) |
|
| 5.619 | ||||
|
| 0.046 |
Comparison of menstrual improvement in the two groups at 3 months after operation.
| Group | Total number of cases | Normal | Increase | Constant |
|---|---|---|---|---|
| Test group | 70 | 49 | 18 | 3 |
| Control group | 70 | 25 | 24 | 21 |
|
| 6.562 | |||
|
| 0.045 |
Comparison of endometrial thickness and RI between the two groups before and after treatment.
| Group total | Number of cases | Observation time | Endometrial thickness (em) | RI |
|---|---|---|---|---|
| Test group | 70 | Preoperative | 4.11 ± 0.61 | 0.72 ± 0.13 |
| 3 months after operation | 6.21 ± 0.80∗ | 0.60 ± 0.10∗ | ||
| Control group | 70 | Preoperative | 4.07 ± 0.57 | 0.74 ± 0.15 |
| 3 months after operation | 6.09 ± 0.76∗∗ | 0.67 ± 0.11∗∗ |
Figure 5Comparison of the effects of patients with moderate and severe intrauterine adhesions.
Figure 6Comparison of the number of readhesions and the degree of readhesion in patients with severe adhesions in each group (%).
Comparison of adverse reaction rates and liver function indexes of patients in each group.
| Group | Number | Adverse reactions/ | AST/U·L−1 | ||||
|---|---|---|---|---|---|---|---|
| Breast tenderness | Breast nodule | Dizziness and headache | Gastrointestinal reaction | Before treatment | After treatment | ||
| Test group | 70 | 1 | 0 | 1 | 3 | 19.51 ± 4.12 | 18.39 ± 3.52 |
| Control group | 70 | 2 | 1 | 1 | 2 | 19.47 ± 44.16 | 18.36 ± 3.17 |
|
| 0.517 | 2.017 | 0.517 | 0.303 | 0.281 | 0.595 | |
|
| 0.773 | 0.365 | 0.772 | 0.859 | 0.998 | 0.912 | |